Analyst Ratings for Inmed Pharmaceuticals (inm)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/16/2022 | Roth/MKM | Scott Henry | Upgrade | Buy (Neutral) |
0.80 (6.00) |
0.83 (1.71) |
106.02% | Details |
| 11/29/2021 | H.C. Wainwright | Raghuram Selvaraju | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.68 (1.71) |
1.79% | Details |
